Escitalopram Oxalate oral soluble Pellicles(Qilu Pharma)

草酸艾司西酞普兰口溶膜(齐鲁制药)

Report date: 2025/07/23 15:37:16

Base Information

Drug NameEscitalopram Oxalate oral soluble Pellicles(Qilu Pharma)
Drug Alias NameEscitalopramum草酸右依地普伦Sipralexa草酸依地普仑Sipralex +[8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitors
TargetsSerotonin transporter
Therapy Area/IndicationsDepressive Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesQilu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDepressive Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A